Compare BMRA & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRA | FLGC |
|---|---|---|
| Founded | 1971 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.6M |
| IPO Year | N/A | 2021 |
| Metric | BMRA | FLGC |
|---|---|---|
| Price | $2.49 | $9.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.5K | ★ 16.1K |
| Earning Date | 01-13-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,884,000.00 | ★ $57,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.71 |
| 52 Week Low | $2.08 | $6.80 |
| 52 Week High | $10.16 | $81.90 |
| Indicator | BMRA | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 46.42 |
| Support Level | $2.26 | $8.09 |
| Resistance Level | $2.39 | $13.70 |
| Average True Range (ATR) | 0.13 | 1.11 |
| MACD | 0.03 | 0.60 |
| Stochastic Oscillator | 76.53 | 34.80 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.